Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze RNAC stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate RNAC investment potential.

What is RNAC stock price today?

Get real-time RNAC stock price, historical data, and price charts on Financhill. Track RNAC performance with our advanced analysis tools.

Is RNAC a good investment?

Evaluate RNAC investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy RNAC stock?

To buy RNAC stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of RNAC?

View detailed market capitalization data and company valuation metrics for RNAC on our comprehensive analysis page.

What is the P/E ratio of RNAC?

Use our fundamental analysis tools to view RNAC P/E ratio and compare valuation metrics with industry peers.

What are RNAC earnings?

View RNAC earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Cartesian Therapeutics, Inc. Stock Predictions

Share Price Moved. Momentum Hasn't Slowed.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

RNAC
Cartesian Therapeutics, Inc.

Last Price:

$8.00

Seasonality Move:

0.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Valuation Up 5,000%. Shares Now $0.85 - Still Early?

Cartesian Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Cartesian Therapeutics, Inc. has on average historically fallen by 18% based on the past 9 years of stock performance.
Cartesian Therapeutics, Inc. has fallen lower in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
Is Cartesian Therapeutics, Inc. Stock Undervalued?

The current Cartesian Therapeutics, Inc. [RNAC] share price is $8.29. The Score for RNAC is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
RNAC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Cartesian Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Cartesian Therapeutics, Inc. has on average historically fallen by 18% based on the past 9 years of stock performance.

Cartesian Therapeutics, Inc. Stock Rating

Sell

Cartesian Therapeutics, Inc. (RNAC) is a Sell

Is Cartesian Therapeutics, Inc. overpriced?

Cartesian Therapeutics, Inc. has fallen lower in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%

Cartesian Therapeutics, Inc. Stock Price History

Is RNAC stock going to rise?

The current trend is moderately bullish and RNAC is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

cartesiantherapeutics.com

52-Week Data

52-Week High:

20.30

52-Week Low:

5.98

Prediction Charts

Market Cap:

215.6M

Price in USD:

8.29

Volume:

239.7K

Beta:

0.85

Technical Analysis

SMA50:

8.15

SMA100:

9.43

SMA200:

10.76

52-Wk Change:

-55.95%

Stock Predictions

Is Cartesian Therapeutics, Inc. stock public?

Yes, Cartesian Therapeutics, Inc. is a publicly traded company.
What is the Cartesian Therapeutics, Inc. stock quote today?

The Cartesian Therapeutics, Inc. stock price is 8.29 USD today.
How to buy Cartesian Therapeutics, Inc. stock online?

You can buy Cartesian Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-26	7.28	7.60	7.61	7.23
Nov-28	7.62	7.49	7.73	7.44
Dec-1	7.41	7.30	7.57	7.20
Dec-2	7.31	6.71	7.31	6.60
Dec-3	6.72	6.65	6.94	6.58
Dec-4	6.62	6.90	7.00	6.53
Dec-5	6.93	6.88	7.08	6.80
Dec-8	6.97	6.72	7.35	6.66
Dec-9	7.16	7.90	8.40	7.11
Dec-10	7.96	7.85	8.18	7.61
Dec-11	7.83	8.45	8.62	7.74
Dec-12	8.44	8.52	8.75	8.20
Dec-15	8.53	8.97	9.23	8.43
Dec-16	8.93	8.29	8.97	7.86

Cartesian Therapeutics, Inc. Earnings

Cartesian Therapeutics, Inc. Earnings Report: Per Share Cartesian Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cartesian Therapeutics, Inc. Forecast Revenue Growth

Cartesian Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Cartesian Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.19 per share, and a decrease next year of $0.65 per share.

* Cartesian Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.